8-K: Philip Morris International Reaffirms 2024 Earnings Forecast at CAGNY Conference

Philip Morris International reaffirmed its full-year 2024 earnings forecast and discussed its progress towards becoming a smoke-free business at the Consumer Analyst Group of New York Conference.

Summary

• Philip Morris International (PMI) presented at the 2024 Consumer Analyst Group of New York (CAGNY) Conference, reaffirming its 2024 full-year forecast for reported diluted EPS of $5.90 to $6.02.
• The company also reaffirmed its adjusted diluted EPS forecast of $6.32 to $6.44, representing a currency-neutral growth of 7% to 9%.
• PMI is focused on transitioning to a smoke-free business by 2030, with smoke-free products accounting for approximately 37% of total net revenues in 2023.
• The company highlighted the success of its multi-category portfolio, including leading brands in heat-not-burn and oral nicotine, and the first anniversary of the Swedish Match combination.
• PMI estimates that approximately 20.8 million adults have switched to IQOS and stopped smoking as of December 31, 2023.
• The company's smoke-free products are available in 84 markets.
• PMI's IQOS net revenues surpassed Marlboro net revenues in Q4 2023.
• The company is targeting over 2/3 of net revenues from smoke-free products by 2030.
• PMI is also expanding into wellness and healthcare through its Vectura Fertin Pharma business.
• The company is seeing strong growth in the U.S. with its ZYN nicotine pouch product.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with reaffirmed financial forecasts and strong progress in the smoke-free transition. The company is showing strong growth in key areas and is well-positioned for the future. However, there are still risks and challenges that need to be addressed.

Positives

• PMI is making significant progress in its transition to a smoke-free business.
• The company's smoke-free products are experiencing strong growth and gaining market share.
• The acquisition of Swedish Match has been successful, with ZYN showing strong growth in the U.S.
• PMI's financial model supports sustainable growth and shareholder returns.
• The company is expanding into new areas such as wellness and healthcare.
• PMI is seeing strong consumer momentum for IQOS in key cities and emerging markets.
• PMI is committed to responsible marketing practices and minimizing underage usage of its products.

Negatives

• The company faces risks related to excise tax increases, regulatory restrictions, and health concerns related to tobacco and nicotine products.
• PMI is subject to litigation related to tobacco use and intellectual property.
• The company is exposed to risks from global economic, regulatory, and political developments, including the impact of the war in Ukraine.
• PMI's future profitability may be affected if it is unsuccessful in commercializing reduced-risk products or if regulations do not differentiate between such products and cigarettes.
• The company faces challenges in integrating recent acquisitions and realizing expected benefits.

Risks

• Excise tax increases and discriminatory tax structures could negatively impact PMI's business.
• Increasing marketing and regulatory restrictions could reduce competitiveness or ban certain products.
• Health concerns related to tobacco and nicotine products and exposure to environmental tobacco smoke pose a risk.
• Litigation related to tobacco use and intellectual property could result in financial losses.
• Intense competition in the market could affect PMI's market share and profitability.
• Global economic, regulatory, and political developments, including the war in Ukraine, could impact the company's operations.
• Changes in adult smoker behavior could affect the demand for PMI's products.
• Unfavorable currency exchange rates and limitations on the ability to repatriate funds could impact financial results.
• Adverse changes in corporate tax laws could increase the company's tax burden.
• The company's ability to produce and commercialize reduced-risk products is subject to regulatory and market risks.

Future Outlook

PMI is focused on achieving its 2024 financial targets and continuing its transition to a smoke-free business, with a goal of over 2/3 of net revenues from smoke-free products by 2030. The company is also focused on deleveraging and maintaining a progressive dividend policy.

Management Comments

• PMI's Chief Executive Officer, Jacek Olczak, and Chief Financial Officer, Emmanuel Babeau, addressed investors at the CAGNY Conference.
• Management highlighted the company's progress in becoming a substantially smoke-free business by 2030.
• Management emphasized the company's strong financial and non-financial performance.

Industry Context

PMI's focus on smoke-free products aligns with the broader industry trend of shifting away from traditional cigarettes towards reduced-risk alternatives. The company's success in this area positions it as a leader in the evolving tobacco market. The acquisition of Swedish Match and the growth of ZYN also reflect the increasing importance of oral nicotine products in the industry.

Comparison to Industry Standards

• PMI's transition to smoke-free products is more aggressive than some of its competitors, such as British American Tobacco and Imperial Brands, which still have a larger focus on traditional cigarettes.
• The growth of PMI's IQOS product is comparable to the growth of other heat-not-burn products in the market, such as Japan Tobacco's Ploom, but PMI has a larger global footprint.
• The success of ZYN in the U.S. market is similar to the growth of other nicotine pouch brands, but PMI has a larger market share.
• PMI's investment in science and research is comparable to other major tobacco companies, but PMI has a stronger focus on harm reduction.

Stakeholder Impact

• Shareholders can expect continued growth and returns as PMI transitions to a smoke-free business.
• Employees will be involved in the company's transformation and expansion into new areas.
• Customers will have access to a wider range of smoke-free products.
• Suppliers will be impacted by the company's shift in focus towards smoke-free products.
• Creditors will be impacted by the company's deleveraging efforts.

Next Steps

• PMI will continue to focus on its smoke-free transformation and achieving its 2024 financial targets.
• The company will continue to invest in its smoke-free product portfolio and expand into new markets.
• PMI will conduct a strategic review of its U.S. cigar business.
• The company will continue to monitor and address risks related to regulatory changes and market conditions.

Key Dates

Keywords

smoke-free products, IQOS, ZYN, heat-not-burn, oral nicotine, reduced-risk products, tobacco, nicotine, Swedish Match, CAGNY Conference, EPS, financial forecast